NCI-H1975 is a lung adenocarcinoma cell line with L858R and T790M EGFR mutations that are sensitive to Osimertinib, whereas PC9 cells have a Del19 EGFR mutation and are also sensitive to Osimertinib. Here, EGFR is linked to lung adenocarcinoma.